SFI Health's Klaire Labs GLP-1 material names the actual side effects of these medications and sets out seven key supplements against the resulting nutrition gaps.
Overview
SFI Health is the parent of Klaire Labs, a practitioner-channel brand with a long-standing reputation particularly in probiotics. Its published GLP-1 material takes an unusual approach for this category: rather than promoting a product, it names the nutrition-related side effects of GLP-1 medications directly, listing nausea, vomiting, constipation, and gas or bloating, and then discusses what supplementation can reasonably do about them.
The framing is careful and accurate. SFI Health states that GLP-1 medications used for weight loss or diabetes can leave nutrition gaps affecting long-term health, and that strategic supplementation can help bridge those gaps, minimise uncomfortable side effects and optimise the benefits of GLP-1 therapy. It then sets out seven key supplements. That is a description of a support role, not a replacement one, and it matches what the evidence supports.
The product range behind it is practitioner-grade rather than GLP-1 specific. Klaire Labs products include a 10-species probiotic blend at 25 billion CFU, alongside a wider catalogue covering digestive, immune and neurological support. What SFI Health does not sell is a GLP-1 branded capsule, which means a buyer following its guidance assembles several products rather than buying one. For someone working with a practitioner that is normal; for a consumer shopping alone it is more work than most competitors require.
SFI Health Klaire Labs GLP-1 Support at a Glance
| Detail | What SFI Health Klaire Labs GLP-1 Support Publishes |
|---|---|
| Type of company | Practitioner-channel supplements, parent of Klaire Labs |
| GLP-1 approach | Guidance and existing products rather than a branded formula |
| Side effects named | Nausea, vomiting, constipation, and gas or bloating |
| Recommendation structure | Seven key supplements against documented nutrition gaps |
| Stated purpose | Bridge gaps, minimise side effects, optimise therapy benefits |
| Example product | A 10-species probiotic blend at 25 billion CFU |
| GLP-1 claims | None; no product claims to raise GLP-1 |
| Channel | Practitioner-focused |
| Published content | Research and science material aimed at clinicians |
| FDA evaluated | No, as with all dietary supplements |
What Is Actually in It
- Published guidance on seven key supplements for GLP-1 users
- Explicit identification of the nutrition-related side effects
- Access to Klaire Labs' practitioner-grade probiotic range
- A 10-species, 25 billion CFU probiotic blend among the products
- Research and science content aimed at clinicians
- No GLP-1 branded product to buy
Supplement or Medication?
Dietary supplements. Nothing in the range claims to affect GLP-1. The published position is that supplementation bridges nutrition gaps and minimises side effects alongside therapy, which is a support role.
How You Buy It
Read the published guidance first
It names the side effects and the seven supplements addressing them.
Identify which side effects you actually have
Nausea, constipation and bloating need different answers.
Consult a practitioner
The brand is practitioner-focused and the guidance assumes clinical input.
Assemble the relevant products
There is no single GLP-1 product to buy.
Who It Is Sold To
- Patients working with a practitioner who stocks Klaire Labs
- Adults on GLP-1 medication with identifiable side effects
- No consultation or clinical assessment involved in a direct purchase
- Immunocompromised people should discuss live probiotics with a clinician
- Not appropriate as a substitute for prescribed obesity treatment
- Best used with clinical guidance on product selection
Clinical Oversight and Evidence
Clinical Oversight
Stronger than most, because the brand is practitioner-focused and its GLP-1 material is written for clinicians managing patients rather than for consumers browsing. Where products are bought through that channel, genuine clinical involvement exists.
Evidence
No GLP-1 specific trials. The published guidance rests on the documented nutrition-related side effects of GLP-1 medications, which are well established, and on the individual literatures of the seven supplements it recommends. Klaire Labs' probiotic products have their own strain-level research.
Availability and Shipping
Where to Buy
Principally through healthcare practitioners, with some consumer access through SFI Health's own channels.
Shipping
Practitioner dispensary and direct shipping. Probiotic products benefit from reasonable temperature handling.
What You Get
- Published clinical guidance naming actual side effects
- A seven-supplement framework rather than a single product pitch
- A long-standing practitioner reputation in probiotics
- Research and science content for clinicians
- A broad product range to select from
- No GLP-1 product, and harder consumer access
Pricing
Practitioner-channel pricing across a range rather than a single GLP-1 product price.
| Product or Plan | Published Price | What It Covers |
|---|---|---|
| Klaire Labs probiotics | Practitioner pricing | Including a 10-species 25 billion CFU blend |
| Wider range | Practitioner pricing | Digestive, immune and neurological support |
| GLP-1 specific product | None | Guidance rather than a branded formula |
| Channel | Practitioner-focused | With some consumer access |
Pricing reflects what SFI Health Klaire Labs GLP-1 Support published at the time of review and can change without notice. Confirm current pricing directly with the seller before buying.
Membership Fees
None, though practitioner dispensaries may operate their own arrangements.
Annual Cost
Depends entirely on which of the seven recommended supplements you take. Assembling several practitioner-priced products is not cheap.
Cancellation and Refund Policy
Cancellation
Depends on the practitioner or channel used.
Refunds
Varies by channel. Practitioner dispensaries operate their own policies.
Insurance, HSA and FSA
Insurance
Not applicable to dietary supplements.
HSA / FSA
Generally not eligible, though the practitioner route may make a letter of medical necessity easier to obtain. Check with your plan administrator.
For a fuller explanation of how these accounts work with GLP-1 care, see our GLP-1 insurance, HSA and FSA guide.
Who SFI Health Klaire Labs GLP-1 Support May Be Best For
- You want to understand which side effects supplements can address
- You are working with a practitioner who stocks Klaire Labs
- You value probiotics from a long-standing specialist
- You prefer guidance to a product pitch
- You are willing to assemble several products
- You want a brand that refuses to claim it raises GLP-1
- No GLP-1 specific product to buy
- Practitioner channel makes consumer access harder
- Practitioner pricing above general retail
- Assembling seven supplements is expensive and complicated
- No GLP-1 specific trials
- Requires clinical input to use as intended
Alternatives to Consider
Pure Encapsulations GLP-1 Protocol
A comparable clinician-designed protocol approach.
Thorne GLP-1 Support Stack
The same idea packaged as a defined four-product bundle.
Replenza GLP-1 Daily Support
A single system covering the same gaps, at chemists.
Seed DS-01 Daily Synbiotic
A probiotic with published trial data, bought at retail.
You can also compare the whole field in our best GLP-1 supplements and GLP-1 supplement evidence review roundups.
Frequently Asked Questions
Does SFI Health sell a GLP-1 product?
No. It publishes guidance identifying the nutrition-related side effects of GLP-1 medications and setting out seven key supplements that address the resulting gaps, drawing on its existing Klaire Labs range.
Which side effects does it name?
Nausea, vomiting, constipation, and gas or bloating. Naming them directly rather than gesturing at wellness is what distinguishes this material from most of the category.
What is the seven-supplement framework?
SFI Health's published position is that GLP-1 medications can leave nutrition gaps affecting long-term health, and that seven key supplements can bridge those gaps, minimise side effects and optimise the benefits of therapy.
What is Klaire Labs?
A practitioner-channel brand owned by SFI Health with a long-standing reputation particularly in probiotics, including a 10-species blend at 25 billion CFU.
Do I need a practitioner to buy it?
The brand is practitioner-focused and the guidance assumes clinical input on product selection, though some consumer access exists.
Does anything in the range raise GLP-1?
No, and nothing claims to. The published framing is explicitly about supporting therapy rather than replacing it.
Is it FDA approved?
No. These are dietary supplements, so they do not require FDA approval before marketing and their claims have not been evaluated by the FDA.